Muhammad Saad Hamid

476 total citations
10 papers, 36 citations indexed

About

Muhammad Saad Hamid is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Muhammad Saad Hamid has authored 10 papers receiving a total of 36 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Muhammad Saad Hamid's work include Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Prostate Cancer Treatment and Research (2 papers). Muhammad Saad Hamid is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Prostate Cancer Treatment and Research (2 papers). Muhammad Saad Hamid collaborates with scholars based in United States, Pakistan and Kenya. Muhammad Saad Hamid's co-authors include Shenhong Wu, Bushra Mina, Kevin Y. Xu, Elisabeth I. Heath, Lance K. Heilbrun, Kiran Devisetty, Mackenzie K. Herroon, Izabela Podgorski, Laura L. Fernandes and Jianguo Zhi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Muhammad Saad Hamid

8 papers receiving 34 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhammad Saad Hamid United States 4 19 15 6 5 3 10 36
Sonal Paul United States 4 16 0.8× 12 0.8× 5 0.8× 7 1.4× 8 2.7× 16 36
David Gutiérrez Abad Spain 4 17 0.9× 41 2.7× 7 1.2× 4 0.8× 4 1.3× 15 59
E. Fonseca Spain 3 13 0.7× 9 0.6× 3 0.5× 6 1.2× 4 1.3× 15 23
Anouk Walter‐Petrich France 4 19 1.0× 15 1.0× 3 0.5× 8 1.6× 6 2.0× 13 42
Laura Leroy France 3 18 0.9× 28 1.9× 5 0.8× 3 0.6× 4 1.3× 8 36
Saad Tahir United Kingdom 4 10 0.5× 23 1.5× 3 0.5× 3 0.6× 5 1.7× 4 29
Jiyu Wen China 3 14 0.7× 36 2.4× 7 1.2× 11 2.2× 3 1.0× 6 48
Li‐Hsin Chien Taiwan 4 10 0.5× 21 1.4× 5 0.8× 4 0.8× 4 1.3× 5 34
Danijela Štrbac Slovenia 5 39 2.1× 6 0.4× 6 1.0× 3 0.6× 4 1.3× 12 50
Julie S. Deutsch United States 5 21 1.1× 26 1.7× 8 1.3× 7 1.4× 12 4.0× 9 43

Countries citing papers authored by Muhammad Saad Hamid

Since Specialization
Citations

This map shows the geographic impact of Muhammad Saad Hamid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Saad Hamid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Saad Hamid more than expected).

Fields of papers citing papers by Muhammad Saad Hamid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Saad Hamid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Saad Hamid. The network helps show where Muhammad Saad Hamid may publish in the future.

Co-authorship network of co-authors of Muhammad Saad Hamid

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Saad Hamid. A scholar is included among the top collaborators of Muhammad Saad Hamid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Saad Hamid. Muhammad Saad Hamid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Allen, Pamela B., Yuan Li, Muhammad Saad Hamid, & Jianguo Zhi. (2025). Racial and Socioeconomic Disparities in Cutaneous T-Cell Lymphoma Survival: Insights From the National Cancer Database. Clinical Lymphoma Myeloma & Leukemia. 25(9). e638–e648.
3.
Hamid, Muhammad Saad, Lance K. Heilbrun, Kiran Devisetty, et al.. (2021). A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer. Advances in Radiation Oncology. 6(4). 100679–100679. 7 indexed citations
4.
Hamid, Muhammad Saad, et al.. (2015). Non-Small-Cell Lung Cancer Clinicopathologic Features and Survival Outcomes in Asian Pacific Islanders Residing in the United States: A SEER Analysis. SHILAP Revista de lepidopterología. 2015. 1–9. 8 indexed citations
5.
Hamid, Muhammad Saad, et al.. (2015). Comparative analysis of the effectiveness of abiraterone before and after docetaxel in patients with metastatic castration-resistant prostate cancer. World Journal of Clinical Oncology. 6(4). 64–64. 9 indexed citations
6.
Hamid, Muhammad Saad, et al.. (2015). Risk of anemia attributable to everolimus in patients with cancer: a meta-analysis of randomized controlled trials.. PubMed. 35(4). 2333–40. 6 indexed citations
7.
Hamid, Muhammad Saad, et al.. (2014). Secondary primary cancers in male breast cancer survivors.. Journal of Clinical Oncology. 32(26_suppl). 129–129. 1 indexed citations
8.
Hamid, Muhammad Saad, et al.. (2014). Non-Small Cell Lung Cancer Clinicopathologic Features and Survival Outcomes in Asian/Pacific Islanders Residing in the United States: A SEER Analysis. International Journal of Radiation Oncology*Biology*Physics. 90(5). S57–S57. 2 indexed citations
9.
Hamid, Muhammad Saad, et al.. (2014). P2Y12 Antagonists: Pharmacology, Efficacy and Patient Considerations. 2 indexed citations
10.
Ali, Rehan, et al.. (2013). Salmonella cholecystitis: atypical presentation of a typical condition.. PubMed. 23(10). 826–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026